Global Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Novo Nordisk

Market Cap: DKK 1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Pfizer

Market Cap: US$142.4b

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally.

Eli Lilly

Market Cap: US$946.3b

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.

Merck

Market Cap: US$249.9b

Operates as a healthcare company worldwide.

Johnson & Johnson

Market Cap: US$502.0b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Tempus AI

Market Cap: US$11.5b

Operates as a healthcare technology company.

Tilray Brands

Market Cap: US$1.4b

A lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally.

CSL

Market Cap: AU$83.9b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Vertex Pharmaceuticals

Market Cap: US$114.1b

A biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis (CF).

Bristol-Myers Squibb

Market Cap: US$108.6b

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.

AbbVie

Market Cap: US$394.8b

A research-based biopharmaceutical company, engages in the research and development, manufacture, commercialization, and sale of medicines and therapies worldwide.

Insmed

Market Cap: US$42.3b

Develops and commercializes therapies for patients with serious and rare diseases in the United States, Europe, Japan, and internationally.

Canopy Growth

Market Cap: CA$906.8m

Engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia.

GSK

Market Cap: UK£72.7b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Incyte

Market Cap: US$19.1b

A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.

Zoetis

Market Cap: US$54.1b

Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.

Telix Pharmaceuticals

Market Cap: AU$4.0b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Sanofi

Market Cap: €99.9b

Engages in the research, development, manufacture, and marketing of therapeutic solutions.

Amgen

Market Cap: US$174.7b

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide.

Roche Holding

Market Cap: CHF 273.4b

Engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand.

Trulieve Cannabis

Market Cap: CA$2.0b

Operates as a cannabis retailer.

Aurora Cannabis

Market Cap: CA$422.4m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Recursion Pharmaceuticals

Market Cap: US$2.4b

Operates as a clinical-stage biotechnology company, engages in the decoding biology and chemistry by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery in the United States.

AstraZeneca

Market Cap: UK£210.1b

A biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines.

Curaleaf Holdings

Market Cap: CA$3.3b

Produces and distributes cannabis products in the United States and internationally.

argenx

Market Cap: €44.6b

A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.

Illumina

Market Cap: US$19.8b

Provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa.

Cresco Labs

Market Cap: CA$1.2b

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Exelixis

Market Cap: US$11.5b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Thermo Fisher Scientific

Market Cap: US$211.4b

Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.

Genmab

Market Cap: DKK 123.4b

A biotechnology company, develops antibody-based products and product candidates for the treatment of cancer and other diseases in Denmark.

Neurocrine Biosciences

Market Cap: US$14.1b

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally.

CRISPR Therapeutics

Market Cap: US$5.2b

A gene editing company, focuses on developing gene-based medicines for serious human diseases using its Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform.

CorMedix

Market Cap: US$902.1m

A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.

Cronos Group

Market Cap: CA$1.6b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

Bayer

Market Cap: €34.8b

Operates as a life science company worldwide.